- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06824389
Evaluate the Performance of Large Language Models in Ophthalmologic Patient Consultation
January 5, 2026 updated by: Zhongshan Ophthalmic Center, Sun Yat-sen University
Evaluate the Performance of Large Language Models in Ophthalmologic Patient Consultation: A Randomized Clinical Trial
The intelligent image models lack an understanding of diagnostic and treatment logic, and have not considered textual information such as symptoms and signs.
Large language models like ChatGPT, can learn medical knowledge, understand, and generate human natural language, offering new technologies for medical knowledge-based intelligent question answering and the creation of smart medical documents.
Therefore, our team plan to verify large language models' feasibility and effectiveness in ophthalmology clinics for medical history collection and examination recommendations during consultations, comparing its performance with traditional methods.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
172
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Guangdong
-
Guangzhou, Guangdong, China
- Zhongshan Ophthalmic Center, Sun Yat-sen University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- No age or gender restrictions for patients.
- Non-emergency ocular diseases including corneal diseases, lens disorders, and vitreoretinal diseases.
- Voluntary participation with signed informed consent.
Exclusion Criteria:
- Top 10 Ocular Emergencies: globe perforation, ocular chemical injury, corneal ulcer perforation, Pseudomonas aeruginosa keratitis, acute angle-closure glaucoma, acute panophthalmitis, central retinal artery occlusion, acute optic neuritis, endophthalmitis, and orbital cellulitis.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Large language models in consultation
After the patient signs the informed consent form, the large language model completes the medical history collection and recommends examinations.
|
Large language model completes the medical history collection and recommends examinations.
|
|
No Intervention: Traditional consultation
After the patient signs the informed consent form, doctor completes the medical history collection and recommends examinations.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Medical History Collection Scoring
Time Frame: through study completion, up to 1 week.
|
The medical history collection is performed using the standard outpatient medical record form.
The scoring criteria are developed collaboratively by clinical doctors from multiple specialties and researchers.
Scoring is independently conducted in a blinded manner by higher-level specialists.
|
through study completion, up to 1 week.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Accuracy of Recommended Tests
Time Frame: through study completion, up to 1 week.
|
The gold standard for both the experimental and control groups consists of test items independently selected by senior specialists, who are not involved in the study.
|
through study completion, up to 1 week.
|
|
Duration of Medical History Collection
Time Frame: through study completion, up to 1 week.
|
The experimental group uses the developed system to record the consultation and medical record writing completion times, while the control group records the consultation time through audio recording and the medical record writing completion time through the developed system.
|
through study completion, up to 1 week.
|
|
Patient satisfaction
Time Frame: through study completion, up to 1 week.
|
Collected through a questionnaire.
|
through study completion, up to 1 week.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 10, 2025
Primary Completion (Actual)
June 10, 2025
Study Completion (Actual)
June 17, 2025
Study Registration Dates
First Submitted
February 5, 2025
First Submitted That Met QC Criteria
February 12, 2025
First Posted (Actual)
February 13, 2025
Study Record Updates
Last Update Posted (Actual)
January 8, 2026
Last Update Submitted That Met QC Criteria
January 5, 2026
Last Verified
January 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- 2025KYPJ004
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Non-emergency Ocular Diseases
-
Sri Ramachandra Institute of Higher Education and...Completed
-
Centre Hospitalier Universitaire DijonCompletedNon-traumatic Medical EmergencyFrance
-
Odense University HospitalHolbaek Sygehus; Slagelse Sygehus; Esbjerg Hospital - University Hospital of...Recruiting
-
University Hospital Bispebjerg and FrederiksbergDoctor Sofus Carl Emil Friis and Mrs Olga Doris Friss' FundCompletedEmergency Department Triage | Non-invasive HemodynamicDenmark
-
Albany Medical CollegeCompletedNon-critical Emergency Room Patients Receiving Lortab Medication or Prescription During Their Emergency Room VisitUnited States
-
Charite University, Berlin, GermanyZentralinstitut für die Kassenärztliche Versorgung in DeutschlandUnknownNon-urgent EmergenciesGermany
-
Chinese University of Hong KongRecruitingNon Communicable Diseases | Health-risk BehavioursHong Kong
-
Chinese University of Hong KongCompletedNon Communicable Diseases | Health-risk BehavioursHong Kong
-
Insel Gruppe AG, University Hospital BernCompletedDamage Control Surgery | Non-traumatic Abdominal EmergenciesSwitzerland
-
Cairo UniversityRecruitingPrimary Open Angle Glaucoma | Subclinical hypothyroïdism | Non-Alcoholic Fatty Liver DiseaseEgypt
Clinical Trials on Consultation Model of large language model in Ophthalmology Clinics
-
John J ChenCompletedCommunication | Interdisciplinary Communication | Artificial Intelligence (AI) | Artificial Intelligence TechnologyUnited States
-
Capital Medical UniversityCompleted
-
Shandong Cancer Hospital and InstituteNot yet recruiting
-
Yale UniversityUniversity of Pennsylvania; George Washington University; World Bank; EHA Clinics...Completed
-
First Affiliated Hospital of Fujian Medical UniversityRecruiting
-
MetroWest Artificial Intelligence Research WorkgroupNot yet recruitingSepsis | Shock | Critical Illness | Acute Kidney Injury | Delirium Confusional State | Multi-organ Failure | Acute Respiratory Failure (ARF)United States
-
Stanford UniversityGoogle LLC.RecruitingGenetic Disease | Cardiomyopathy | Cardiology | Hypertrophic Cardiomyopathy (HCM)United States
-
Peking University Third HospitalQingdao Municipal Hospital; Tianjin Medical University General Hospital; The... and other collaboratorsRecruitingHeart Failure With Preserved Ejection FractionChina
-
Tsinghua UniversityNot yet recruiting